Cargando…

179P Efficacy and safety of extended-interval dosing strategy of immune checkpoint inhibitors during the COVID-19 outbreak: Experience from a single center

Detalles Bibliográficos
Autores principales:	Pierre, C., Goter, T., Agar, C., Luzi, S., Lena, H., Guen, Y. Le, Ricordel, C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Association for the Study of Lung Cancer. Published by Elsevier Inc. Published by Elsevier Inc. 2021
Materias:	Advanced Nsclc
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997779/ http://dx.doi.org/10.1016/S1556-0864(21)02021-9

Ejemplares similares

182P Impact of SARS CoV 2 outbreak in the molecular diagnosis of advanced NSCLC: A retrospective comparative cohort study
por: Marin, E., et al.
Publicado: (2021)

180P Incidence of brain metastases (BM) in newly diagnosed stage IV NSCLC during COVID-19
por: Cui, W., et al.
Publicado: (2021)

Sécurité et efficacité de l’immunothérapie selon un schéma double dose dans le CBNPC avancé : étude rétrospective multicentrique IDEE
por: Pierre, C., et al.
Publicado: (2023)

The Peninsula stage III non-small cell lung cancer audit: assessing the impact of COVID-19 on treatment decisions
por: Smith, Philippa, et al.
Publicado: (2023)

Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study
por: Cantini, Luca, et al.
Publicado: (2023)

Crizotinib治疗ALK阳性伴骨髓转移的肺腺癌1例及文献复习
Publicado: (2015)

EML4-ALK融合基因阳性肺腺癌合并淋巴瘤1例并文献复习
Publicado: (2015)

非小细胞肺癌患者EML4-ALK融合基因突变研究
Publicado: (2015)

ALK阳性非小细胞肺癌患者克唑替尼耐药的机制和治疗措施
Publicado: (2015)

初露端倪——演绎ALK阳性非小细胞肺癌的中国故事
Publicado: (2015)

增强免疫组化和原位杂交方法检测非小细胞肺癌的ALK重排的临床可行性
Publicado: (2015)

ALK阳性非小细胞肺癌的诊断
Publicado: (2015)

Extended-Interval Dosing Strategy of Immune Checkpoint Inhibitors in Lung Cancer: Will it Outlast the COVID-19 Pandemic?
por: Sehgal, Kartik, et al.
Publicado: (2020)

Multinational Analysis of Estimated Health Care Costs Related to Extended-Interval Fixed Dosing of Checkpoint Inhibitors
por: Goldstein, Daniel A., et al.
Publicado: (2023)

Impact of extended interval dosing of immune checkpoint inhibitors in lung cancer patients during the COVID-19 pandemic
por: Veron, Marie, et al.
Publicado: (2023)

Safety and Efficacy of Extended Interval Dosing for Immune Checkpoint Inhibitors in Non–Small Cell Lung Cancer During the COVID-19 Pandemic
por: Hijmering-Kappelle, L.B.M., et al.
Publicado: (2022)

Extended-Interval Gentamicin Dosing for Pulmonic Tularemia
por: Dietrich, Tyson, et al.
Publicado: (2019)

Pharmacodynamics of natalizumab extended interval dosing in MS
por: Zhovtis Ryerson, Lana, et al.
Publicado: (2020)

S179. PROGNOSTIC UTILITY OF MULTIVARIATE MORPHOMETRY IN SCHIZOPHRENIA
por: Li, Mingli, et al.
Publicado: (2018)

Interval regression model adequacy checking and its application to estimate school dropout in Brazilian municipality educational scenario
por: do Nascimento, Rafaella L. S., et al.
Publicado: (2022)

Health Tract, No. 179: Stammering
Publicado: (1863)

Health Tract, No. 179: Stammering
Publicado: (1865)

Regression models for interval censored data using parametric pseudo-observations
por: Johansen, Martin Nygård, et al.
Publicado: (2021)

Extending Classification Algorithms to Case-Control Studies
por: Stanfill, Bryan, et al.
Publicado: (2019)

Safety and efficacy of extended dosing intervals of denosumab in patients with solid cancers and bone metastases: a retrospective study
por: Abousaud, Aseala I., et al.
Publicado: (2020)

Erratum: memorandum on the PS 179 experiment
por: CERN. Geneva. Proton Synchrotron and Synchrocyclotron Committee
Publicado: (1983)

179 Responsible Conduct of Research for Undergraduates
por: Moses, Jennifer, et al.
Publicado: (2022)

Evaluation of Extended Interval Dosing Aminoglycosides in the Morbidly Obese Population
por: Ross, Ashley L., et al.
Publicado: (2013)

A sinogram denoising algorithm for low-dose computed tomography
por: Karimi, Davood, et al.
Publicado: (2016)

Analysis of the interaction between Zinc finger protein 179 (Znf179) and promyelocytic leukemia zinc finger (Plzf)
por: Lin, Ding-Yen, et al.
Publicado: (2013)

in silico Surveillance: evaluating outbreak detection with simulation models
por: Lewis, Bryan, et al.
Publicado: (2013)

Real-World Effectiveness of Natalizumab Extended Interval Dosing in a French Cohort
por: Pelle, Juliette, et al.
Publicado: (2023)

A framework for extending trial design to facilitate missing data sensitivity analyses
por: Mason, Alexina J., et al.
Publicado: (2020)

Evaluation of risk of nephrotoxicity with high dose, extended-interval colistin administration
por: Dewan, Arun, et al.
Publicado: (2014)

Effectiveness of lanreotide autogel 120 mg at extended dosing intervals for acromegaly
por: Bernabéu, Ignacio, et al.
Publicado: (2020)

Extended-Interval Dosing of Rezafungin against Azole-Resistant Aspergillus fumigatus
por: Wiederhold, Nathan P., et al.
Publicado: (2019)

Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19
por: Rolfes, Leoni, et al.
Publicado: (2021)

The alpha decay of $^{179}$Hg and $^{178}$Hg
por: Hansen, P G, et al.
Publicado: (1971)

The alpha decay of $^{179}Hg$ and $ ^{178}Hg$
por: Hansen, P G, et al.
Publicado: (1971)

Antiproton interaction with light nuclei (PS179)
por: Bendiscioli, G
Publicado: (1982)

Cannot write session to /tmp/vufind_sessions/sess_tmgp32avql20oe3dj9kg0h471g